Il Registro Nazionale Italiano per la Distrofia Muscolare Facioscapolo-omerale: uno strumento per la diagnosi e la prognosi avanzate nelle malattie neuromuscolari
Year: 2021
Type: dissertation
Study design: Observational Study
Abstract: Facioscapulohumeral muscular dystrophy (FSHD) is the third most common muscular myopathy with a prevalence of 1 in 20,000.So far, FSHD is considered an autosomal dominant disease with incomplete penetrance.The classic FSHD phenotype is characterized by onset in the first or second decade of life with progressive facial, shoulder girdle, and pectoral muscle weakness and atrophy, often asymmetric.The disease has been associated (95%) with reduced number (≤ 10 units) of tandemrepeats (D4Z4) in the subtelomeric region of chromosome 4q35.However, genotypephenotype studies have shown that D4Z4 alleles with 4-10 repeat units are also present in 3-5% of general healthy population.Moreover, a 5-10% of patients with FSHD carry D4Z4 alleles within the range of the general population (≥11 RU) and represent a second form of disease, called FSHD2.From 1992 to the present, numerous evidences have accumulated indicating that FSHD is not transmitted as a simple Mendelian trait, but must be considered a complex disease to whose development numerous factors contribute.From 2007 to 2020, the Miogen laboratory of the University of Modena and Reggio Emilia has collected 7550 subjects in the Italian National Register for FSHD (INRF) of 5965 molecularly diagnosed families and 1585 single cases.Thanks to the Italian Clinical Network for FSHD, it was possible to collect standardized clinical information using the Comprehensive Clinical Evaluation Form (CCEF), from 2013 with prototype and from 2016 with actual version.It is a tool designed to describe the clinical heterogeneity of FSHD: in fact, the diagnosis and genetic counseling are further complicated by a variable phenotypic spectrum observed in subjects carrying the molecular defect, which can express with extremely different characteristics.Based on these premises, we analyzed the families collected from 1993 to 2020, to obtain an epidemiological context of the phenotypic spectrum.Our analysis re-evaluated penetrance and highlighted clinical differences between carriers of the D4Z4 small-sized alleles (DRA) and their families.In particular, we investigated family trios composed by the affected subject and its healthy parents in order to identify alternative genetic mechanisms by exploiting the WGS/WES technology.Moreover, we examine criteria for the preimplantation genetic diagnosis (PGD), testing feasibility use of microsatellite D4S1523 and two VNTR (D4S139 and D4S163), proximal to D4Z4, studying recombination in the segregation of three generations families with phase.These observations have the power to uncover additional factors involved in the risk of developing FSHD and to clarify the role of the reduction of D4Z4 elements in the 4q35 locus in the different myopathic phenotypes.Our work demonstrates the value of centralizing molecular and clinical diagnosis of rare disease and aims at the reconsideration of criteria for the diagnosis of the FSHD.This work represents the implementation of precision medicine, which by integrating clinical and genetic elements can create a phenotypic ontology that could distinguish a patient from others with similar Mendelian conditions and lay the basis for personalized treatments.
Authors: Tupler, Rossella, De Luca, Michele, Napoli, Floriana Maria
Institution: University of Modena and Reggio Emilia
Language: Italian
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7066289779
